GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

BCYC · Sep 30, 2026

BICYCLE THERAPEUTICS PLC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001104659-26-119864General Corporate

Capex intensity0thOwn-history percentile · N=9

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.90% · OPTIONAL · VALID

Operating cash generation100thOwn-history percentile · N=9

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-118.34% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

190.24% · CORE · NOT_ENOUGH_HISTORY

Operating margin100thOwn-history percentile · N=9

Evidence method

Level · gp.fundamentals.operating_margin

-39.57% · CORE · VALID

R&D intensity0thOwn-history percentile · N=9

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

98.14% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=9

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

15.91% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History1 statesHistory building

Sep 30, 20265/6 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Decreased

Previous: 42.13%
Current: 0.90%
Delta: -41.23%

Cash Generation Increased

Previous: -7886.49%
Current: -118.34%
Delta: 7768.15%

Growth Increased

Previous: -78.46%
Current: 190.24%
Delta: 268.70%

Profitability Increased

Previous: -8673.93%
Current: -39.57%
Delta: 8634.35%

R And D Intensity Decreased

Previous: 6543.72%
Current: 98.14%
Delta: -6445.58%

Sbc Intensity Decreased

Previous: 1018.12%
Current: 15.91%
Delta: -1002.22%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Compared To · Pharmaceutical Preparations peers →Derived From · BCYC Company Quality Vector →Has State · BICYCLE THERAPEUTICS PLC →Transitioned To · BCYC CAPEX_INTENSITY_DECREASED →Transitioned To · BCYC CASH_GENERATION_INCREASED →Transitioned To · BCYC GROWTH_INCREASED →Transitioned To · BCYC PROFITABILITY_INCREASED →Transitioned To · BCYC R_AND_D_INTENSITY_DECREASED →Transitioned To · BCYC SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.